Search

everythinglearnresearchcommunity

for

Search:↓

Type I interferons play a key role in the development of various skin diseases.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Stem cell niches support, regulate, and coordinate stem cell functions.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Lowering testosterone speeds up wound healing in male mice.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Some alopecia treatments might help treat COVID-19, but more research is needed.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

HIV can cause unusual and severe skin problems that are hard to treat.